Everolimus for Epilepsy - campaign update

We have submitted feedback to NICE on the draft policy document regarding Everolimus for Epilepsy and the integrated impact assessment. Our CEO Maxine Smeaton has this week received notice that the Scottish Medicines Council is also about to open its consultation, and the TSA will be working with them on this very soon. Thank you all for your continued support for this campaign and please watch this space for further updates.